The effect of an abuse‐deterrent opioid formulation (OxyContin) on opioid abuse‐related outcomes in the postmarketing setting-Reference-Cited by-同舟云学术

The effect of an abuse‐deterrent opioid formulation (OxyContin) on opioid abuse‐related outcomes in the postmarketing setting

Author:

Coplan PM¹²,Chilcoat HD¹³,Butler SF⁴,Sellers EM⁵⁶,Kadakia A¹,Harikrishnan V¹,Haddox JD⁷⁸,Dart RC⁹¹⁰

Affiliation:

1. Department of Risk Management and EpidemiologyPurdue Pharma L.P.Stamford Connecticut USA

2. Adjunct, Epidemiology DepartmentUniversity of Pennsylvania Perelman School of MedicinePhiladelphia Pennsylvania USA

3. Department of Mental HealthJohns Hopkins Bloomberg School of Public HealthBaltimore Maryland USA

4. Inflexxion Inc.Newton Massachusetts USA

5. DL Global Partners IncToronto Canada

6. Pharmacology and Toxicology, Medicine and PsychiatryUniversity of TorontoToronto Canada

7. Department of Health PolicyPurdue Pharma L.P.Stamford Connecticut USA

8. Department of Public Health & Community Medicine, School of MedicineTufts UniversityBoston Massachusetts USA

9. Rocky Mountain Poison & Drug CenterDenver Colorado USA

10. Surgery and MedicineUniversity of Colorado Health Sciences CenterDenver Colorado USA

Funder

Purdue Pharma L.P.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference49 articles.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献